Previous studies showed that PD-L2 is expressed in pancreatic ductal adenocarcinoma, non-small-cell lung cancer, glioma, and HCC and high PD-L2 expression is associated with poor prognosis [8,11,12,13,14,15,16]. This evidence concerns the gene PDCD1LG2 and pancreatic ductal adenocarcinoma.